Guardian Pharmacy Services, Inc.
GRDN · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.03 | -1.24 | 0.24 | -3.28 |
| FCF Yield | 3.31% | 5.78% | 3.26% | 5.06% |
| EV / EBITDA | -29.68 | 17.72 | 15.20 | 21.80 |
| Quality | ||||
| ROIC | -35.89% | 26.20% | 32.40% | 22.13% |
| Gross Margin | 19.89% | 19.91% | 20.45% | 20.36% |
| Cash Conversion Ratio | -0.82 | 1.88 | 0.98 | 2.07 |
| Growth | ||||
| Revenue 3-Year CAGR | 10.56% | 9.72% | 7.29% | 4.29% |
| Free Cash Flow Growth | -26.08% | 77.20% | -35.48% | 11.17% |
| Safety | ||||
| Net Debt / EBITDA | -0.75 | 1.16 | 0.92 | 0.86 |
| Interest Coverage | -19.19 | 14.32 | 26.99 | 18.42 |
| Efficiency | ||||
| Inventory Turnover | 24.27 | 22.81 | 17.45 | 19.06 |
| Cash Conversion Cycle | 5.92 | 5.66 | 8.73 | 7.21 |